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Epidemiologic and Spatial Differences in Colorectal, Lung, Breast, and Prostate
Cancer Mortality-to-Incidence Ratios between Blacks and Whites in Louisiana
Anas Almatrafi, BSc, December, 2017

Abstract

Mortality and Incidence rates are widely used as indicators of health disparities
among different racial groups. The current study used the mortality-to-incidence ratio
(MIR) to provide a better population-based indicator of survival that can be used as an
alternative and more accurate measure of the fatality based on incidence. This study
intended to calculate and map MIRs for colorectal, lung and bronchus, breast and prostate
cancers in Louisiana by race (Blacks vs Whites), sex, age groups, and geography. Ageadjusted mortality and incidence rates were calculated using the latest data release of the
Surveillance, Epidemiology, and End Results (SEER) Program (1973-2014). ). The study
population was Louisiana Black and White residents who were diagnosed/died with
primary colorectal, lung and bronchus, breast or prostate cancers during the period 20102014. ArcGIS Desktop 10.5 was used to visually illustrate the MIRs by race (Blacks and
Whites) and sex, when appropriate across the 17 Health Service Areas (HSAs) of
Louisiana. Black men MIRs were higher than White men MIRs for each cancer site and
for all age groups combined. Black women MIRs were higher than White women MIRs
for the majority of age groups. The larger and only significant differences between Blacks
and Whites were observed for the overall MIR of breast and prostate cancers and for each
age group. This study utilized MIRs to describe cancer fatality and disparities in Louisiana.
Larger MIRs were detected for blacks compared to whites for breast and prostate cancers.
More fatal cancers were detected in North and Northwest of Louisiana, and less fatal
cancers were detected in the Northeast and South of Louisiana. Compared to national white
MIRs, geographic differentials were detected. Regional MIR patterns were observed and

need additional cancer prevention and control research in the highlighted geographic areas
and population subgroups.
Introduction
Cancer is the second leading cause of death in the United States, with a projected
600,920 cancer deaths estimated to occur in 2017(Siegel, Miller, & Jemal, 2017). Prostate
(for men), breast (for women), lung, and colorectal cancers for both men and women are
the top cancers regarding incidence and mortality rates in the United States (Siegel et al.,
2017). The overall cancer death rate in the United States had dropped by 25% in 2014
compared to its peak in 1991 as a result of tobacco smoking reduction, increased prevention
measures, early detection and treatment advancements (Siegel et al., 2017). Despite this
decline, racial and ethnic minorities are more likely to have higher cancer mortality rates
and shorter survival times compared to the general population of the United States. Lack
of health care coverage and low socioeconomic status (SES) are among the top factors that
are associated with cancer disparities in the United States (National Cancer Institute, 2008).
Black American males have the highest all cancer combined incidence and mortality rates
that are 11% and 24% higher, respectively, than non-Hispanic Whites(Siegel et al., 2017).
The differences in incidence between ethnic groups might be also due to differences in
exposures related to cancer and variation of etiologic factors between ethnic groups. The
state of Louisiana (LA) is located in the southeastern region of the United States between
Texas and Mississippi and south of Arkansas. The population estimates of Louisiana was
4,681,666 in 2016 (U.S. Census Bureau, 2016). Louisiana has one of the highest all-cancer
combined mortality rates in the nation, with an overall national ranking of the 4th highest
mortality for the period of 2010 to 2014 (191 per 100,000). Blacks in Louisiana also have

high rates of all-cancer mortality (223.5 per 100,000) compared to the national morality
rate of 166.1 per 100,000, to the non-Hispanic Whites in LA (183.7 per 100,000), and even
higher than the national cancer mortality rate for blacks (194.2 per 100,000) (U.S. Cancer
Statistics Working Group, 2017). White males and females in LA diagnosed at regional
and distant stages had a significantly higher survival compared to black males and females
in the same diagnostic categories. The five most frequently diagnosed cancers in Louisiana
are (1) prostate, (2) lung, (3) breast, (4) colorectal, and (5) kidney cancers (L. et al., 2015).
Cancer health disparities, as defined by NCI, are “adverse differences in cancer incidence,
cancer prevalence, cancer death, cancer survivorship, and burden of cancer or related health
conditions that exist among specific population groups in the United States” (National
Cancer Institute (NCI), 2008). Previous studies have highlighted some of the cancer health
disparities in LA for some cancer sites but were limited to specific geographic areas in LA.
Most of these studies used mortality rates widely as indicators of health disparities among
different racial groups. However, using mortality rates without accounting for incidence
can result in inaccurate conclusions (Hebert et al., 2009). The current study used the
mortality-to-incidence ratio (MIR) to provide a population-based indicator of survival that
can be used as an alternative and more accurate measure of the fatality based on incidence.
It has been suggested that MIR is considered as a good and valid proxy of the 5-year
relative survival for the majority of cancer sites (Asadzadeh Vostakolaei et al., 2011).
Recently, mapping MIRs have been used to illustrate cancer disparities among different
racial groups in the United States (Babatunde et al., 2016; Hebert et al., 2009; Wagner et
al., 2012). This MIR ratio can be calculated by dividing the age-adjusted mortality rate by
the age-adjusted incidence rate for each cancer site or for all cancer sites combined (Hebert

et al., 2009). The current study utilized data of the state of Louisiana because of the
availability of high quality population-based cancer registry in the state. Focusing on
Louisiana was also important because the large proportion of Black population in the state
(32.6% of Louisiana population) and the significant disparity in cancer incidence and
mortality between Blacks and Whites (U.S. Census Bureau, 2016). The current study
intended to calculate and map MIRs for colorectal, lung and bronchus, breast and prostate
cancers in Louisiana by race (Blacks vs Whites), sex and age groups, for the period 2010
to 2014. These cancer sites represent the 4 most frequent cancers in Louisiana, and they
reflect different survival patterns (L. et al., 2015).
Methods
The Surveillance, Epidemiology, and End Results (SEER) Program Registry
The Surveillance, Epidemiology, and End Results (SEER) Program of the National
Cancer Institute provide data on cancer in order to reduce the cancer burden among the
U.S. population. SEER is supported by the Surveillance Research Program, which offers
national leadership in the science of cancer surveillance, analytical tools, and
methodological expertise in collecting, analyzing, interpreting, and disseminating reliable
population-based figures. SEER collects data on cancer cases through many locations and
sources within the United States. Data collection started in 1973 with a limited number of
registries and expanded to include more areas and demographics as of today. The state of
Louisiana has entered SEER program in 2001 with first year full of data beginning from
2000.
Louisiana Health Service Areas (HSAs)

This study used Louisiana HSAs as its unit of allocation to visually illustrate the
MIRs differences between Blacks and Whites compared to the national MIRs for each
cancer site and for each sex when applicable. Health service area is originally defined as
“one or more counties that are relatively self-contained with respect to the provision of
routine hospital care” (Makuc, Haglund, Ingram, Kleinman, & Feldman, 1991). Louisiana
contains 17 HSAs that cover all of the 64 Parishes, with at least two parishes included in
each area with the exception of four areas that include one parish each (Claiborne, Madison,
St. Mary and Winn parishes). Louisiana map was obtained from Louisiana Department of
Transportation then was divided into the 17 HSAs using ArcGIS Desktop (Version 10.5.1).
Data management and Statistical Analysis
For calculating MIRs, age-adjusted mortality and incidence rates were calculated
using the latest release of SEER database (1973-2014). The study used the period of 2010
to 2014 because it is the latest 5 years available data for the state of Louisiana and to avoid
the effect of migration following Hurricane Katrina in 2005. All Rates were calculated per
100,000 and age-adjusted to the 2000 US Standard Population (19 age groups - Census
P25-1130). The study population was Louisiana Black and White residents who were
diagnosed/died with primary colorectal, lung, breast or prostate cancers during the period
2010-2014. In situ cancers were excluded from analysis because most in situ cases are not
likely to result in death from these cancers a short period. The MIRs ratios were calculated
as age-adjusted mortality rate divided by age-adjusted incidence rate for colorectal, lung,
breast and prostate cancers for each Blacks and Whites and each sex, when applicable. The
95% confidence intervals for MIRs were calculated using F intervals suggested by a
previously validated method (Fay, 1999). For comparison of MIRs on the map of

Louisiana, a previously suggested MIRs categorization was used to produce the following
4 categories (Hebert et al., 2009); a) the upper bound of Category 1 is the average MIR for
whites males nationally; b) the upper bound of Category 2 is 10% higher than the upper
bound of Category 1; c) the upper bound of Category 3 is 20% higher than the upper bound
of Category 1; d) Category 4 consists of MIRs that are >20% higher than the national mean
for whites (upper bound of category 1). In addition, the national average MIRs for Black
males and Black females were used to compare Louisiana Black population to the national
Black ratios using the same method of categorization listed above. The SEER*Stat
(Version 8.3.4) and Microsoft Excel were used to calculate rates and MIRs respectively.
ESRI ArcGIS Desktop (Version 10.5.1) was used to visually illustrate the MIRs by race
(Blacks and Whites) and sex, when appropriate across Louisiana's HSAs.
Results
There were a total of 61,516 incident cases identified in Louisiana for colorectal,
lung and bronchus, breast and prostate cancers during the period 2010 to 2014. In total,
23,345 cancer deaths were identified in SEER for the above cancer sites during the same
period. Tables 1 and 2 show Louisiana age-adjusted incident and mortality rates,
respectively, for the selected cancer sites by age groups, race (Black and White), and sex
retrieved from SEER*Stat for the period 2010 to 2014. Table 3 displays the MIRs and its
95% CIs for colorectal, lung and bronchus, breast, and prostate cancers by age groups, race
(Black and White) and sex. Black men MIRs were higher than White men MIRs for each
cancer site and for all age groups combined. Black women MIRs were higher than White
women MIRs for the majority of age groups. These racial differences in MIRs were
statistically significant for all age groups of breast cancer and for all but the first two age

groups of prostate cancer (Table 3). The largest differences in MIRs between Blacks and
Whites were observed for the overall breast cancer MIR and for all age groups (Blacks:
Whites range: 1.47-2.21) (Table 3). Lung and bronchus cancer was the most fatal cancer
(MIR range: 0.43 to 0.96), while prostate cancer was the least fetal cancer (MIR rang: 0.02
to 0.55). Table 4 shows the MIRs for colorectal, lung and bronchus, breast, and prostate
cancers by Louisiana HSAs, race (Black and White), and sex. All MIRs in Table 4 were
used to depict the differences between Blacks and Whites over the Louisiana 17 HSAs
(Appendix1) using 4 categories based on the national average MIRs for Whites
(Appendices 2-7) and Blacks (Appendices 8-13) for each cancer site and each sex, when
appropriate. For male colorectal cancer, Whites had only one area (Concordia, Tensas)
with category-4 MIR (i.e., > 20% higher than the average MIR for whites) compared to
Blacks who had 5 areas with category-4 MIR (Appendix2). When Black males were
compared to the national average Black male MIR for colorectal cancer, the rates showed
higher MIRs in only 6 areas out of the 17 HSAs (Appendix8). For female colorectal cancer,
both Blacks and Whites had some areas (9 HSAs for Black and 7 for whites) that are higher
than the national average MIR for Whites or category-1 (Appendix3). When Black females
were compared to the national average Black female MIRs for colorectal cancer, the rates
showed higher MIRs in only 5 areas out of the 17 HSAs (Appendix9). For lung and
bronchus cancer, White males showed category-2 MIRs (i.e. up to 10% higher than the
national MIR) for all HSAs but 3 areas compared to Blacks which had 1 area with category4 MIR and 5 areas with category-3 MIR (Appendix4). When MIRs for Black males were
compared to the national average Black MIRs for lung and bronchus cancer, the rates
showed higher MIRs in all but 5 HSAs (Appendix10). White female lung and bronchus

cancer MIRs were higher than the national White female MIR in nearly all HSAs for both
Blacks and Whites (Appendix5). Black females also had higher MIRs than the national
Black female MIRs for lung and bronchus cancer in all but one HSA (Appendix11). For
breast cancer, Blacks had category-4 MIR in all HSAs (14 HSAs) compared to Whites that
had only 4 HSAs with category-4 (Appendix6). Black females also had higher MIRs than
the national average Black MIR for breast cancer in almost all HSAs (Appendix12). For
prostate cancer, White males showed comparable MIRs to the national white MIRs across
all HSAs (Appendix7). Black males had also comparable MIRs to the national MIR in all
the majority of HSAs with 2 areas that had category-4 MIRs (Appendix7). When Black
males were compared to the national Black prostate cancer MIR, they showed comparable
MIRs over all but 2 HSAs (Appendix13). The HSAs of Lincoln and Union, Terrebonne
and Lafourche, and Concordia and Tensas had the most category-4 MIRs appearances (6,
5 and 4 appearances respectively) (Appendices 2-7). In contrast, the HSAs that comprises
Lafayette and Iberia, Ouachita and Morehouse, East Baton Rouge and Livingston, and St.
Tammany and Washington parishes had the most category-1 MIRs appearances (6, 6, 5,
and 5 appearances respectively) (Appendices 2-7). The HSA that includes Lincoln and
Union parishes, located in the northern part of Louisiana, had the least category-1 MIR
appearance (only 1 appearance) (Appendices 2-7). On the contrary, the HSA that includes
Orleans and Jefferson parishes had the least category-4 MIR (Only 1 appearance)
(Appendices 2-7).

Table 1. Age-adjusted incidence rate* of Colorectal, Lung and Bronchus, Breast, and Prostate Cancers
in Louisiana by age groups, race (Black and White) and sex in SEER for the period 2010 to 2014.

Age group

White Males
Incidence Rate

White Females
Incidence Rate

Black Males
Incidence Rate

Black Females
Incidence Rate

Colorectal Cancer
15-44 years

6.7

7.4

5.5

7.5

45-54 years

55.8

47.1

74.1

68.4

55-64 years

111.1

71.6

170.5

108.3

65-74 years

203.5

134.2

283.2

184.9

75+ years

284.6

208

301.4

234.2

Total

50.9

37.4

64.9

49.1

Lung & Bronchus
15-44 years

2.3

3.1

3.8

1.9

45-54 years

58.1

48.7

78.7

48.3

55-64 years

167

125.1

263.4

117.1

65-74 years

411.2

280

501.4

247.9

75+ years

552.5

307

644

251.1

Total

106.8

71.1

136.5

62.5

Breast Cancer
White
Black

Prostate Cancer
White
Black

Age group

Incidence Rate

Incidence Rate

Incidence Rate

Incidence Rate

15-44 years

33.7

35.8

2.3

2.7

45-54 years

186.6

214.5

88.8

173.1

55-64 years

293.2

318.2

379.1

604

65-74 years

411.5

431.9

752

1,131.80

75+ years

387.8

380.1

532.5

806.5

Total

117.7

127.7

127.2

199.7

*Rates calculated as number of cases per 100,000 individuals at risk and age-adjusted to the 2000 US standard population (19 age
groups - Census P25-1130).

Table 2. Age-adjusted mortality rate* of Colorectal, Lung and Bronchus, Breast, and Prostate Cancers
in Louisiana by age group, race (Black and White) and sex in SEER for the period 2010 to 2014.

Age group

White Males

White Females

Black Males

Black Females

Mortality rate

Mortality rate

Mortality rate

Mortality rate

Colorectal Cancer
15-44 years

1.8

1.5

2.1

2

45-54 years

14.4

11.9

27

15

55-64 years

36

22.8

61.4

39

65-74 years

69.3

46.9

113.5

72

75+ years

146.7

106.9

190.3

127.8

Total

19.5

13.5

29.5

19.1

Lung & Bronchus
15-44 years

1

2.1

2

0.8

45-54 years

42.1

31.5

58.6

31.2

55-64 years

121.4

81.3

198.6

80.1

65-74 years

310.4

201.8

419.6

178.9

75+ years

505.3

288.4

605.9

241.5

Total

86.2

54.7

115.1

48.3

Breast Cancer
White
Black

Prostate Cancer
White
Black

Age group

Mortality rate

Mortality rate

Mortality rate

Mortality rate

15-44 years

2.8

6.7

^

^

45-54 years

21

48.1

1.8

6.4

55-64 years

43.2

77.9

12.3

31.8

65-74 years

71

120.6

48

111.8

75+ years

130.6

168.6

219

447.5

20.2
34.8
18.2
38.5
Total
*Rates calculated as number of cases per 100,000 individuals at risk and age-adjusted to the 2000 US standard population (19 age
groups - Census P25-1130).

^ Statistic not displayed due to fewer than 10 cases in this group.

Table 3. Mortality-to-Incidence Ratios (MIR) and 95% Confidence Intervals for Colorectal, Lung and Bronchus, Breast, and Prostate
Cancers in Louisiana by age groups, race (Black and White) and sex for the period 2010 to 2014.

Cancer site: sex, age subgroups
Colon & Rectum
Men

Whites

Age group

MIR

95% CI

MIR

15-44 years

0.384

0.249-0.579

0.273

95% CI
0.198-0.37

45-54 years

0.364

0.294-0.449

0.258

0.214-0.308

1.41

0.324

0.286-0.366

1.11

0.341

0.304-0.381

1.18
1.23

55-64 years
65-74 years

Women

Blacks

0.360
0.401

0.308-0.419
0.339-0.472

Black:White Ratio
1.41

75+ years

0.631

0.522-0.762

0.515

0.465-0.571

Total

0.415

0.381-0.452

0.367

0.346-0.390

1.18

0.209

0.147-0.29

1.43

0.252

0.206-0.307

0.89
1.12

15-44 years
45-54 years

0.299
0.224

0.203-0.433
0.174-0.286

55-64 years

0.358

0.299-0.427

0.319

0.273-0.371

65-74 years

0.387

0.322-0.463

0.350

0.306-0.398

1.11

0.514

0.466-0.566

1.06
1.00

75+ years

0.546

0.462-0.644

Total

0.377

0.345-0.412

0.377

0.354-0.402

15-44 years

0.525

0.329-0.825

0.448

0.281-0.698

1.17

0.725

0.64-0.82

1.03

0.727

0.674-0.785

1.04
1.11

Lung & Bronchus
Men

45-54 years
55-64 years

0.837

0.759-0.923

0.755

75+ years

0.941

0.839-1.055

0.915

0.86-0.973

1.03

0.793

0.765-0.822

1.03

0.674

0.478-0.946

0.65
1.00

15-44 years

0.814
0.438

0.770-0.859
0.216-0.843

45-54 years

0.647

0.528-0.791

0.648

0.563-0.745

55-64 years

0.684

0.596-0.784

0.650

0.594-0.711

1.05

0.720

0.671-0.773

1.00

0.940

0.879-1.005

1.02
0.98

75+ years

0.722
0.962

0.635-0.819
0.84-1.101

Total

0.754

0.703-0.809

0.769

0.739-0.8

15-44 years*

0.187

0.151-0.229

0.084

0.066-0.106

2.21

0.113

0.098-0.129

1.99

0.147

0.133-0.163

1.66
1.62

45-54 years*
55-64 years*

0.224
0.245

0.195-0.257
0.217-0.275

65-74 years*

0.279

0.244-0.319

0.173

0.156-0.19

75+ years*

0.443

0.386-0.509

0.337

0.31-0.366

1.32

0.181

0.173-0.190

1.47

^

^

^
1.83

Total*
Male Prostate

0.684-0.83

65-74 years

65-74 years

Female Breast

0.754

0.633-0.875

0.71-0.803

Total
Women

0.744

15-44 years

0.267

^

0.251-0.284

^

45-54 years

0.037

0.025-0.054

0.020

0.012-0.032

55-64 years*

0.053

0.043-0.063

0.032

0.027-0.039

1.62

0.064

0.056-0.072

1.55
1.35
1.38

65-74 years*

0.099

0.085-0.114

75+ years*

0.555

0.492-0.625

0.411

0.379-0.445

Total *

0.197

0.175-0.231

0.143

0.138-0.149

CI= confidence interval, MIR= mortality-to-incidence ratio. * A statistically significant difference was found in the MIR between Blacks and Whites based on non-overlapping
95% CIs. ^ Statistic not displayed due to fewer than 10 cases in this group.

Table 4. Mortality-to-Incidence Ratios (MIR) for Colorectal, Lung and Bronchus, Breast, and Prostate Cancers in Louisiana by Health Service Area (HSA), race
(Black and White) and sex for the period 2010 to 2014.
Colon and Rectum
Whites

Lung & Bronchus

Blacks

Whites

Breast

Blacks

Prostate

Whites

Blacks

Whites

Blacks

Men

Women

Men

Women

Men

Women

Men

Women

Women

Women

Men

Men

HAS #

HSA

MIR

MIR

MIR

MIR

MIR

MIR

MIR

MIR

MIR

MIR

MIR

MIR

416

Caddo (Shreveport) - Bossier

0.414

0.359

0.501

0.448

0.783

0.752

0.872

0.767

0.162

0.235

0.149

0.233

470

Calcasieu (Lake Charles) - Vernon

0.371

0.398

0.402

0.283

0.852

0.799

0.947

0.785

0.178

0.276

0.131

0.103

523

Claiborne

-

-

-

-

0.588

0.618

0.708

-

-

-

-

-

435

Concordia - Tensas

0.500

-

-

-

0.713

0.971

0.830

0.787

0.253

0.385

-

-

419

0.371

0.350

0.515

0.392

0.830

0.800

0.910

0.774

0.158

0.265

0.096

0.153

424

East Baton Rouge (Baton Rouge) Livingston
Lafayette (Lafayette) - Iberia

0.328

0.318

0.441

0.340

0.801

0.773

0.767

0.802

0.176

0.263

0.131

0.156

439

Lincoln - Union

0.418

0.442

0.549

0.458

0.836

0.826

0.865

0.919

0.260

0.366

0.144

0.223

431

Madison

-

-

-

-

-

-

0.610

-

-

-

-

-

403

Orleans (New Orleans) - Jefferson

0.377

0.412

0.431

0.404

0.789

0.780

0.838

0.740

0.168

0.296

0.163

0.179

443

Ouachita (Monroe) - Morehouse

0.321

0.320

0.413

0.319

0.801

0.694

0.728

0.824

0.179

0.325

0.135

0.338

450

Rapides (Alexandria) - Avoyelles

0.435

0.408

0.332

0.377

0.815

0.712

0.875

0.608

0.234

0.245

0.184

0.189

463

St. Landry - Evangeline

0.405

0.319

0.426

0.376

0.834

0.776

0.825

0.818

0.197

0.297

0.136

0.163

528

St. Mary

0.417

0.303

0.531

0.386

0.855

0.731

0.869

0.869

0.156

0.222

0.080

0.166

500

St. Tammany (Slidell) - Washington

0.382

0.334

0.413

0.535

0.815

0.777

0.798

0.720

0.157

0.253

0.157

0.199

423

Tangipahoa - St. Helena

0.326

0.487

0.456

0.352

0.796

0.834

0.788

0.791

0.174

0.285

0.142

0.257

467

Terrebonne (Houma) - Lafourche

0.450

0.401

0.471

0.552

0.778

0.744

0.773

0.935

0.224

0.321

0.146

0.204

530

Winn

-

0.491

-

-

0.871

0.746

-

-

-

-

-

-

Appendix1. Louisiana map displays the 17 Health Service Areas (HSAs).

Discussion/Recommendations
The current study used mortality and incidence data to investigate cancer distribution by
race, sex, and geography. It has been previously described that Blacks in general, for the majority
of cancer sites, have elevated cancer incidence and mortality rates in the U.S. and in Louisiana
than Whites (U.S. Cancer Statistics Working Group, 2017). However, mortality or incidence rates
alone might not be an accurate measures to investigate cancer fatality and possible racial disparities
between Blacks and Whites. For example, the Black to White ratio of female breast cancer
incidence (B:W=1.08) and mortality (B:W=1.72) rates are notably different compared to the MIR
of breast cancer (B:W= 1.35). The MIR allows for efficient comparison of the disparities, when
exist, in cancer mortality accounting for incidence. This current study is the first study that used
MIR in Louisiana to provide a population-based approximation of survival without conducting

detailed survival studies. Overall, Black males and females in Louisiana in this study had elevated
MIRs than whites for colorectal, lung and bronchus, and prostate cancers. The MIRs for males
were higher than the ratios for females across almost all age groups. These findings are consistent
with what was reported from South Carolina (Hebert et al., 2009) and Georgia (Wagner et al.,
2012). The only exception in the differences between males and females MIRs was observed in
the age group of 14-44 for lung and bronchus cancer, in which the MIR was 51% higher among
white females compared to white Males. The most interesting finding of this study was the
significant differences that were observed in MIRs between Blacks and Whites in Louisiana for
female breast cancer (B:W=1.47) and male prostate cancer (B:W=1.39). The remarkable
differences were observed when MIRs were calculated by age groups. For example, breast cancer
MIRs among Black females in the age groups of 14-44, 45-54, and 55-64 were 2.2, 1.8, and 1.6
times the MIRs for White females, respectively. This was also observed for prostate cancer as
MIRs for Black males in the age groups of 45-54 and 55-64 were 1.8 and 1.6 times the MIRs for
Whites, respectively. In general, the differences in MIRs between Blacks and Whites in Louisiana
were comparable for colorectal, lung and bronchus, and breast cancers to those of South Carolina
(Hebert et al., 2009) and Georgia (Wagner et al., 2012). However, the prostate cancer Black to
White MIR in Louisiana was 16% and 19% lower than what was observed in Georgia and South
Carolina, respectively. Colorectal and prostate cancers MIRs for Blacks were lower in Louisiana
than South Carolina (Hebert et al., 2009) and Georgia (Wagner et al., 2012). Breast cancer MIRs
for blacks were lower in Louisiana compared to South Carolina (Hebert et al., 2009) and
comparable to those of Georgia (Wagner et al., 2012). Lung and bronchus cancer MIRs for Blacks
in Louisiana were comparable to both South Carolina (Hebert et al., 2009) and Georgia (Wagner
et al., 2012). White males in Louisiana had comparable colorectal cancer MIRs to White males in

South Carolina (Hebert et al., 2009) and Georgia (Wagner et al., 2012), while white females’
colorectal cancer MIRs were slightly higher than those of South Carolina (Hebert et al., 2009) and
Georgia (Wagner et al., 2012). For lung and bronchus cancer, White males MIRs in Louisiana
were close to those of Georgia (Wagner et al., 2012) and lower than South Carolina (Hebert et al.,
2009). While White females lung and bronchus cancer MIRs in Louisiana were comparable to
those of South Carolina (Hebert et al., 2009) and slightly higher than Georgia (Wagner et al.,
2012). For female breast cancer, White MIRs in Louisiana were similar to those of South Carolina
(Hebert et al., 2009) and Georgia (Wagner et al., 2012). Prostate cancer MIRs were lower among
Whites in Louisiana compared to Whites in South Carolina (Hebert et al., 2009) and Georgia
(Wagner et al., 2012). Additionally, mapping MIRs for the evaluated cancer sites by sex and race
(Black and White) across the 17 HSAs of Louisiana showed notable differences. Compared to the
national White MIR for each cancer site and each sex when appropriate, the worst cancer outcomes
across all evaluated cancer sites were observed in the HSAs of Lincoln and Union (North of LA),
Terrebonne and Lafourche (Southeast of LA), and Concordia and Tensas (northeast of LA). Of the
12 sex-race MIR combinations in Lincoln-Union area, 6 were more than 20% higher than the
national white MIR. Breast cancer MIR in this HSA was 130% higher in Blacks and 50% higher
in Whites compared to the national White MIR. The best cancer outcome was observed in the
HSAs of Ouachita (Monroe)-Morehouse (Northeast of LA) and Lafayette-Iberia (South of LA).
Surprisingly, the worst and best cancer outcomes were observed in HSAs that are located next to
each other (i.e. Lincoln-Union and Ouachita-Morehouse areas). Identification of HSAs with worst
cancer outcomes and with large disparities is crucial to implement area-specific cancer screening,
prevention, and/or research programs that will help in understanding the etiological factors that
contributed to these differences. Cancer incidence and mortality SEER data that we used in this

study are of high quality and completeness with highly validated racial and sex information. This
study used 5 years combined data to obtain a representative sample across the HSAs of Louisiana
to provide reliable rates. Additionally, this is the first study that used cancer MIR in Louisiana as
a valid approximation of the 5-year survival. However, the relationship between the numerator
(mortality) and the denominator (incidence) may not be direct. This is because some individuals
who are diagnosed with cancer do not die of cancer directly but from other comorbidities that they
might have. In and out migration might be a possible limitation of this study due to the nature of
Louisiana after Hurricane Katrina in 2005. However the current study used data from 2010-2014
in which out migration rates declined significantly compared to the migration rate of 2005 and
2006. Future studies should focus more on the geographic areas and/or population subgroups with
the worst cancer outcomes that have been identified in this study. Additionally, linkage of SEER
with Medicare, Medicaid, hospitals, and Federally Qualified Health Centers (FQHCs) can help
better understanding of the current cancer disparities in Louisiana and other states.
Conclusion
In summary, this study utilized MIRs to describe cancer fatality and disparities in
Louisiana. Larger MIRs were detected for blacks compared to whites for breast and prostate
cancers. More fatal cancers were detected in North and Northwest of Louisiana, and less fatal
cancers were detected in the Northeast and South of Louisiana. Compared to national MIRs,
geographic differentials were detected. Louisiana had significantly larger MIRs for the majority
of evaluated cancer sites. The consistency of our findings with the sex and racial disparities in
South Carolina and Georgia suggests common healthcare utilization factors in cancer management
between Southern states. Regional MIR patterns were observed and need additional cancer
prevention and control research in the highlighted geographic areas and population subgroups.

References
Asadzadeh Vostakolaei, F., Karim-Kos, H. E., Janssen-Heijnen, M. L., Visser, O., Verbeek, A. L., & Kiemeney, L.
A. (2011). The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. Eur J
Public Health, 21(5), 573-577. doi:10.1093/eurpub/ckq120
Babatunde, O. A., Adams, S. A., Eberth, J. M., Wirth, M. D., Choi, S. K., & Hebert, J. R. (2016). Racial disparities
in endometrial cancer mortality-to-incidence ratios among Blacks and Whites in South Carolina. Cancer
Causes Control, 27(4), 503-511. doi:10.1007/s10552-016-0724-7
Fay, M. P. (1999). Approximate confidence intervals for rate ratios from directly standardized rates with sparse data.
Communications in Statistics-Theory and Methods, 28(9), 2141-2160.
Hebert, J. R., Daguise, V. G., Hurley, D. M., Wilkerson, R. C., Mosley, C. M., Adams, S. A., . . . Bolick-Aldrich, S.
W. (2009). Mapping cancer mortality-to-incidence ratios to illustrate racial and sex disparities in a highrisk population. Cancer, 115(11), 2539-2552. doi:10.1002/cncr.24270
Louisiana Department of Transportation 'Parish Boundaries of Louisiana, Geographic NAD83, (2005) [parishes].
Makuc, D. M., Haglund, B., Ingram, D. D., Kleinman, J. C., & Feldman, J. J. (1991). Health service areas for the
United States. Vital Health Stat 2(112), 1-102.
National Cancer Institute. (2008). Cancer Health Disparities, Retrieved October 10, 2017, from
https://www.cancer.gov/about-nci/organization/crchd/cancer-health-disparities-fact-sheet
Siegel, R. L., Miller, K. D., & Jemal, A. (2017). Cancer Statistics, 2017. CA: a cancer journal for clinicians, 67(1),
7-30.
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database:
Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2016 Sub
(2000-2014) <Katrina/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969-2015
Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2017, based
on the November 2016 submission.
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database:
Mortality - All COD, Aggregated With County, Total U.S. (1969-2014) <Katrina/Rita Population
Adjustment> - Linked To County Attributes - Total U.S., 1969-2015 Counties, National Cancer Institute,
DCCPS, Surveillance Research Program, released December 2016. Underlying mortality data provided by
NCHS (www.cdc.gov/nchs).
Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.gov/seerstat)
version 8.3.4.
U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2014 Incidence and Mortality Webbased Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and
Prevention and National Cancer Institute; 2017. Available at: www.cdc.gov/uscs.
U.S. Census Bureau. (2016, July 1). Louisiana Quick Facts. Retrieved from https://www.census.gov/quickfacts/LA
Wagner, S. E., Hurley, D. M., Hebert, J. R., McNamara, C., Bayakly, A. R., & Vena, J. E. (2012). Cancer mortalityto-incidence ratios in Georgia: describing racial cancer disparities and potential geographic determinants.
Cancer, 118(16), 4032-4045. doi:10.1002/cncr.26728

Acknowledgements
I would like to express my acknowledgements to every person who helped my through this
journey. First acknowledgement goes to my Committee chair Dr. Soliman for believing in me and
being always helpful and patient whenever I needed him. My second acknowledgement is to be
delivered to Dr. Al Kharusi for having me in Oman and his kindness in serving as my preceptor.
Most importantly, I would like to thank my wife Nawal for her support and being helpful in taking
care of our lovely son Muath through this project.

Service Learning/Capstone Experience Reflection
My service learning activates at OCA during this period was primarily involved with breast
cancer data entry, verification, and cleaning. I continued working on data entry during the first
week of the reported period. My service learning activates ranged from direct data entry of
questionnaires into electronic excel database, in addition to data entry team supervision. These
data was retrieved from breast cancer suspected cases that undergrown mammography screening
in Oman. During this period, we started to look for data that we missed on the last weeks. The data
files we used were mainly from the years 2016 and 2013 where these files were stored on a shelf
that is separate from all data. The team I worked with were undergrad students from nursing
college and they were requited for one month to help with data entry. I managed to lead this team
to make sure they understand the steps of data entry properly in the given time period. In addition
to data entry, I was responsible to compile all excel data files by taking copies from the team’s
laptops into one final excel database at the end of each day. This step allowed us to keep track of
what have been done and to make sure that we have a new data backup on a daily bases. The next
step during the reported period was data cleaning. We started to clean the data by correcting
spelling mistakes, capitalizations, date formats and duplicates. It took about two days to clean
around 14,000 records by three people including myself. After that, we took random number of
records and verify their entry to check the quality of data entry. Further verification will be
performed on data by OCA staff in the future.
During my stay at OCA, I learned how health-related non-profit organizations work in
Oman. OCA is an organization that operates under the umbrella of the Ministry of Social
Development. The association have benefited from this government support in employing full time
Omani staff that being paid by the government. In addition, there are some volunteers who that

work regularly for OCA. For example, I met one of the radiologist who volunteered to read the
screening results of the mobile mammography and he has been doing this for years. Meeting this
radiologist gave me an idea about how OCA benefited from some volunteers to help their
operation. This organization run by board of directors and a president who is also the chairman of
board. I think OCA run by this way as board of directors is the best model for nonprofit
organizations in the region because it compose of well-connected people that facilitate mission
and vision of OCA. The board include oncologists, university professors, and community leaders.
Working in OCA opened my eyes more to the leadership and management skills and how
leaders lead. Being close to the employees and the director of OCA helped me to understand how
different tasks and responsibilities are assigned. Through this close observation, I have learned
that not all tasks are suitable for everyone. Therefore, leaders should treat each individual in the
organization based on his or her skills and capabilities to account for their individual differences.
I also have learned that as leader, you need to not be lean and be more serious in certain occasions.
Another thing that I observed is that leadership and management is skills that polishes with
experience and time. This experience indeed enhance my leadership skills from observing the
director of OCA and his way of leading the organization. I feel that I developed theses skills during
my time at OCA as I lead the data entry team.
I have learned that I can adapt easily to new working environment and get along with most
people rapidly. For my own leadership style, I learned that I need to be more serious when leading
a team and to separate work duties from any personal or emotional decisions. Some of the team I
worked with were similar to my age and I found it difficult for me at the beginning to give orders
or comments on their achievements and progress.

On the other hand, my capstone experience gave me the chance to directly apply what I
learned about conducting an epidemiological study. Starting from writing the study proposal to
presenting the final project, I managed to learn new skills and tools which helped me in achieving
the objectives of the project and answering my research question.
The first thing I learned and enhanced during this period was to conduct a proper literature
review. Even though I did write many literature review for previous projects or classes, this one
was special in a way that took a lot of time and focus. I got exposed to many great resources and
references that are focused on cancer in the U.S. which helped me in my project. What also make
this literature review experience so unique for me is the fact that I reached out to some articles’
authors to clarify some concepts and get more details about their papers. This is actually the first
time I have done that.
The second significant experience during this period was working on a high quality
surveillance data from the SEER registry. This journey started by signing a SEER data-use
agreement to gain access to the data and to ensure that I comply with their data using policy. Using
SEER data has allowed me to deal with large data sets to extract and report significant findings. I
learned about most of the variables that are used by SEER and got exposed to different data sets
that are provided by SEER especially for cancer incidence and mortality. Also, I managed to work
on SEER*Stat software that has been provided by SEER. This experience has opened my eyes to
the concept of big data and data science as a path for my future career.
The third learning experience was using new tools for the first time for data analysis and
data visualization. For data analysis, I used SEER*Stat and RStudio software. SEER*Stat was
very helpful in calculating and extracting incidence and mortality data for my capstone project. I
start by spending some time learning how to deal with this new program and ended up using it as

intended. The other program I used for data analysis was RStudio, in which I calculated the 95%CI
of the mortality-to-incidence ratios. This software was the most challenging one because it requires
some coding to produce results. I literally spend hours learning how to write efficient code that
could produce the desired results. I am glad I have learned to code using R language as I intended
to continue use this program for future data analysis and research. For the data visualization part,
I used ArcGIS to produce high quality epidemiological maps. Mapping data was something that I
never done before and I can state that I enjoyed working on maps and perform spatial analysis.
Using these new tools has enabled me to know my skills and what I am capable of to achieve the
tasks and objectives of my capstone project. This will shape my future practice as a public health
expert.
I have learned a lot about myself through this journey. First, I learned that I am willing to
learn and adopt to new concepts and tools quickly. At the time of writing my proposal I had no idea
how I am going to use SEER data, use R software, or produce epidemiological maps. The one thing
I know that I just need to learn the fundamentals to use these tools; and this is what I did. The second
thing that I learned about my self is my ability and enjoyment to work on large data set such as SEER
data. I literally enjoyed every step of the data analysis part of my capstone project. I enjoyed working
with and calculating rates and ratios in addition to producing high quality epidemiological maps.
Discovering theses abilities and skills will definitely shape my future career.
The last notable learning experience was the comments and feedback that I received from
my committee during this period. My committee chair was always there when I needed help and I
really benefited from his valuable comments on every aspect of the project.
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